Pregabalin and Gabapentin set to reclassify to controlled drugs (CD)

by | Dec 22, 2017 | Blog

With official figures showing pregabalin related deaths to 111 and gabapentin related deaths to 59, the Home Office launched on 13th November three options for the reclassification of these two drugs.

The options for its reclassification includes schedule 3, this would mean fulfilling the requirement for them to be stored in a safe locked storage.

The fear within community pharmacy is further costs – to have a large enough suitable locked storage cabinet that is ideally bolted against a wall. If your current CD cabinet has enough space, then you’re fine, but the likelihood is that you require the space and room.

On the other hand, wholesalers would require a CD Home Office licence to ensure they can continue their business. However, not knowing what category these two drugs would go under makes it difficult to apply for the current licence, so you must wait. We play the waiting game.

Testimonials

Having just completed the very informative API and Clinical Trail course (thank you Shankar) I was reminded of the traps we can fall into whereby we try to keep ourselves in our little boxes. At the MHRA symposium, I have heard several times comments such as:- “no, I’m not doing the GMP day as it’s not relevant to me” or “GDP? Oh, that doesn’t apply to us as we are manufacturers”. I am sure these comments were made well out of the earshot of MHRA personnel and on the face of it see… Read more
API and Clinical Trails Training